NHS Staffordshire and Stoke-On-Trent Integrated Care Board

Funded awards at NHS Staffordshire and Stoke-On-Trent Integrated Care Board.

Funded awards
9
Total Funding
£10.1M
Average published award
£1.1M
Active funded awards
1

Data as of 16 July 2026

The biggest topic here is Bones, Joints & Muscles — 5 grants (56%). The busiest year was 2019, with 2 grants.

Funded Awards by Year

View data table
YearFunded awards
20091
20141
20151
20181
20192
20201
20211
20221

Grants

Maximising outcome for patients with shoulder pain: using optimal diagnostic and prognostic information to target treatment (PANDA-S)NHS Staffordshire and Stoke-on-trent Integrated Care BoardNIHR£2.8M2018Active
Improving outcomes for patients with opioid-treated persistent non-cancer pain: a proactive clinical pharmacist-led primary care intervention (PROMPPT intervention).ACRONYM: Pharmacist-led intervention to Reduce inappropriate use of Opioid Medicines and optimise Persistent Pain Therapy (PROMPPT)NHS Staffordshire and Stoke-on-trent Integrated Care BoardNIHR£2.7M2019Completed
Stratified Primary Care for Musculoskeletal PainNHS Staffordshire and Stoke-on-trent Integrated Care BoardNIHR£1.9M2014Completed
Addressing Child and Adolescent Musculoskeletal Pain: the CAM-Pain ProgrammeNHS Staffordshire and Stoke-on-trent Integrated Care BoardNIHR£1.5M2022Completed
Enhancing quality care for older adults with osteoarthritis: a knowledge mobilization case study and recommendations for primary careNHS Staffordshire and Stoke-on-trent Integrated Care BoardNIHR£346K2015Completed
Explaining osteoarthritis: development and implementation of a multimedia Patient Explanation Package (PEP-OA)NHS Staffordshire and Stoke-on-trent Integrated Care BoardNIHR£272K2019Completed
Development and implementation of support for pharmacists to deliver integrated primary care for osteoarthritis: a mixed methods investigation and evaluation (PharmOA)NHS Staffordshire and Stoke-on-trent Integrated Care BoardNIHR£248K2021Completed
Safety of colchicine prophylaxis when initiating urate-lowering therapy for gout and prognostic factors for adverse events: an observational study in UK primary care using the Clinical Practice Research DatalinkNHS Staffordshire and Stoke-on-trent Integrated Care BoardNIHR£134K2020Completed
In-Practice FellowshipNHS Staffordshire and Stoke-on-trent Integrated Care BoardNIHR£111K2009Completed